| COVID-19 and risks to the supply and quality of tests, drugs, and vaccines PN Newton, KC Bond, M Adeyeye, M Antignac, A Ashenef, GR Awab, ... The Lancet Global Health 8 (6), e754-e755, 2020 | 158 | 2020 |
| The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world? PJ Guerin, S Singh-Phulgenda, N Strub-Wourgaft F1000Research 9, 2020 | 79 | 2020 |
| Global access to quality-assured medical products: the Oxford statement and call to action PN Newton, KC Bond, P Newton, K Bond, V Abiola, K Ade-Abolade, ... The Lancet Global Health 7 (12), e1609-e1611, 2019 | 35 | 2019 |
| Baseline results of a living systematic review for COVID-19 clinical trial registrations BJ Maguire, ARD McLean, S Rashan, ES Antonio, J Bagaria, Z Bentounsi, ... Wellcome Open Research 5, 2020 | 24 | 2020 |
| Affordability of adult HIV/AIDS treatment in developing countries: modelling price determinants for a better insight of the market functioning L Sagaon‐Teyssier, S Singh, B Dongmo‐Nguimfack, JP Moatti Journal of the International AIDS Society 19 (1), 20619, 2016 | 21 | 2016 |
| Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis S Singh-Phulgenda, P Dahal, R Ngu, BJ Maguire, A Hawryszkiewycz, ... PLoS Neglected Tropical Diseases 15 (3), e0009302, 2021 | 18 | 2021 |
| Gender disparity in cases enrolled in clinical trials of visceral leishmaniasis: A systematic review and meta-analysis P Dahal, S Singh-Phulgenda, PL Olliaro, PJ Guerin PLoS neglected tropical diseases 15 (3), e0009204, 2021 | 16 | 2021 |
| Visceral Leishmaniasis in pregnancy and vertical transmission: A systematic literature review on the therapeutic orphans P Dahal, S Singh-Phulgenda, BJ Maguire, E Harriss, K Ritmeijer, F Alves, ... PLoS neglected tropical diseases 15 (8), e0009650, 2021 | 15 | 2021 |
| The creation and evolution of the donor funded market for antimalarials and the growing role of southern firms F Orsi, S Singh, L Sagaon-Teyssier Science, Technology and Society 23 (3), 349-370, 2018 | 10 | 2018 |
| The fragmented COVID-19 therapeutics research landscape: a living systematic review of clinical trial registrations evaluating priority pharmacological interventions. ARD McLean, S Rashan, L Tran, L Arena, AA Lawal, BJ Maguire, S Adele, ... Wellcome Open Research 7 (24), 24, 2022 | 7 | 2022 |
| Infectious diseases data Observatory (IDDO) visceral Leishmaniasis library of clinical therapeutic studies: A protocol for a living systematic review of clinical studies S Singh-Phulgenda, S Rashan, E Harriss, P Dahal, C Naylor, M Brack, ... Wellcome Open Research 7 (155), 155, 2022 | 6 | 2022 |
| Systematic review of the scrub typhus treatment landscape: Assessing the feasibility of an individual participant-level data (IPD) platform K Saraswati, BJ Maguire, ARD McLean, S Singh-Phulgenda, RC Ngu, ... PLoS Neglected Tropical Diseases 15 (10), e0009858, 2021 | 6 | 2021 |
| Entry and operation strategies of Indian pharmaceutical firms in Africa under the dynamics of markets and institutions S Singh Aix-Marseille, 2018 | 6 | 2018 |
| Baseline results of a living systematic review for COVID-19 clinical trial registrations PJ Guérin, BJ Maguire, ARD McLean, S Rashan, ES Antonio, J Bagaria, ... Wellcome open research 5, 1-26, 2020 | 5 | 2020 |
| Knowledge, attitudes and behaviors on antimicrobial resistance among general public across 14 member states in the WHO European region: results from a cross-sectional survey S Singh-Phulgenda, P Antoniou, DLF Wong, K Iwamoto, K Kandelaki Frontiers in Public Health 11, 1274818, 2023 | 3 | 2023 |
| Estimating the proportion of relapse following treatment of Visceral Leishmaniasis: meta-analysis using Infectious Diseases Data Observatory (IDDO) systematic review R Chhajed, P Dahal, S Singh-Phulgenda, M Brack, C Naylor, S Sundar, ... The Lancet Regional Health-Southeast Asia, 2023 | 2 | 2023 |
| Design, conduct, analysis, and reporting of therapeutic efficacy studies in visceral Leishmaniasis: a systematic review of published reports, 2000-2021 P Dahal, S Singh, C Naylor, M Brack, M Chatterjee, F Alves, PJ Guerin, ... medRxiv, 2023.09. 06.23295148, 2023 | 2 | 2023 |
| The Market for Artemisinin-Based Combination Therapies and the New Era of “Market Makers” S Singh, F Orsi HAL Post-Print, 2018 | 2 | 2018 |
| Safety and efficacy of primaquine in patients with Plasmodium vivax malaria from South Asia: a systematic review and individual patient data meta-analysis R Verma, RJ Commons, A Gupta, M Rahi, PK Bharti, K Thriemer, ... BMJ Global Health 8 (12), e012675, 2023 | 1 | 2023 |
| Haematological dynamics following treatment of visceral leishmaniasis: a protocol for systematic review and individual participant data (IPD) meta-analysis A Munir, P Dahal, R Kumar, S Singh-Phulgenda, NA Siddiqui, C Naylor, ... BMJ open 13 (12), e074841, 2023 | 1 | 2023 |
